José Sifuentes‐Osornio

Author

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ORCID

Also Known As

*J Sifuentes-Osornio, Andrea Rangel-Cordero, Diego Luis Carrillo Perez, Erick Rosales Uribe, J Sifuentes, J Sifuentes Osornio, J Sifuentes-Osornio, J. Sifuentes, J. Sifuentes-Osornio, JOSE SIFUENTES-OSORNIO

312

Publications

25K

Citations

H-Index

114

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Instituto Nacional de Salud Pública Universidad Nacional Autónoma de México Instituto Nacional de Enfermedades Respiratorias Stanford University

About

José Sifuentes‐Osornio is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	40	4K
2	Public Health	14	15	2.8K
3	Health Sciences	12	12	842
4	Engineering	1	1	15
5	Allergy	1	1	43

José Sifuentes‐Osornio

130

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Mohsen Naghavi, Kevin S Ikuta, Lucien R Swetschinski, The Lancet Global BurdenAntimicrobial SusceptibilityAntimicrobial StewardshipAntibioticsMedicine	2024	2.2K
Global Phylogeny of<i>Mycobacterium tuberculosis</i>Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set Ingrid Filliol, Alifiya S. Motiwala, Magali Cavatore, Journal of Bacteriology	2005	434
Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Manzour Hernando Hazbón, Michael Brimacombe, Miriam Bobadilla-del-Valle, Antimicrobial Agents and Chemotherapy Isoniazid Resistance MutationsGeneticsTuberculosis PreventionAntibiotic ResistanceDrug Resistance	2006	383
Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey Márcio Nucci, Flávio Queiroz‐Telles, Tito Alvarado-Matute, PLoS ONE	2013	368
Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes María Eugenia Jiménez-Corona, Luis Pablo Cruz‐Hervert, Lourdes García‐García, Thorax	2012	291
Tuberculosis and Diabetes in Southern Mexico Alfredo Ponce‐de‐León, Lourdes García‐García, Ma. Cecilia García-Sancho, Diabetes Care	2004	246
In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation Antonio Olivas‐Martínez, José Luis Cárdenas-Fragoso, José Víctor Jiménez, PLoS ONE	2021	146
Epidemiology of Invasive Fungal Infections in Latin America José Sifuentes‐Osornio, Dora Corzo-León, Alfredo Ponce‐de‐León Current Fungal Infection Reports Fungal VirusFungal PathogenInternational HealthFungal BiologyLatin America	2012	127
Clinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern Mexico Lourdes García‐García, Alfredo Ponce‐de‐León, María Eugenia Jiménez-Corona, Archives of Internal Medicine	2000	116
Role of <i>embB</i> Codon 306 Mutations in <i>Mycobacterium tuberculosis</i> Revisited: a Novel Association with Broad Drug Resistance and IS <i>6110</i> Clustering Rather than Ethambutol Resistance Manzour Hernando Hazbón, Miriam Bobadilla-del-Valle, Marta Inírida Guerrero, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionMolecular BiologyPathologyAntibiotic ResistanceDrug Resistance	2005	115

Page 1